You have 1 action to finish to complete your account. Customize your experience by selecting your interests on the Personalization page
No matches

114 search results for: patient burden

Pediatric Asthma <b>Patient</b> Case Tool: Ash
interactivity

Pediatric Asthma Patient Case Tool: Ash

Pulmonology
Review a patient case to learn more about identifying uncontrolled asthma and type 2 inflammation in pediatric patients
View more
The Evolving Understanding of Prurigo Nodularis (PN) Has Implications for <b>Patient</b> Management
Infographic

The Evolving Understanding of Prurigo Nodularis (PN) Has Implications for Patient Management

Dermatology
An infographic summarizing the clinical manifestations and pathophysiological processes of PN.
View more
Adult Asthma Interactive <b>Patient</b> Cases
interactivity

Adult Asthma Interactive Patient Cases

Pulmonology
Explore 3 hypothetical patient cases using guideline-based checklists for assessment and diagnosis of type 2 inflammation in adult asthma
View more
Chronic Spontaneous Urticaria (CSU) Interactive <b>Patient</b> Case
interactivity

Chronic Spontaneous Urticaria (CSU) Interactive Patient Case

Dermatology
Learn more about the guideline-based diagnosis of chronic spontaneous urticaria with this interactive patient case.
View more
On-Treatment Clinical Remission in Asthma <b>Patient</b>s Case Tool
interactivity

On-Treatment Clinical Remission in Asthma Patients Case Tool

Pulmonology
Review a severe asthma patient case to learn more about assessing asthma control and on-treatment clinical remission.
View more
ERS 2024 | Airway Remodeling: A Permanent or Transitory Consequence in Severe Asthma <b>Patient</b>s?
expert video

ERS 2024 | Airway Remodeling: A Permanent or Transitory Consequence in Severe Asthma Patients?

Pulmonology
Professors Celeste Porsbjerg and Klaus Rabe and Dr Mario Castro discuss the pathophysiology of airway remodeling and its impact on patients with severe asthma.
View more
Comorbidities and Disease <b>Burden</b> in CSU
expert video

Comorbidities and Disease Burden in CSU

Dermatology
In their interview Drs. Maurer and Ensina shed light on the significant burden of comorbidities in CSU.
View more
Targeting Type 2 Inflammation: ​Skin Barrier Normalization​
expert video

Targeting Type 2 Inflammation: ​Skin Barrier Normalization​

Dermatology
Highlights from ESPD 2023 ADVENT: Uncovering how type 2 inflammation influences skin barrier dysfunction in atopic dermatitis.
View more
ERS 2024 | Understanding Remission as a Treatment Goal in Pediatric Severe Asthma – <b>Patient</b> Case Introduction
expert video

ERS 2024 | Understanding Remission as a Treatment Goal in Pediatric Severe Asthma – Patient Case Introduction

Pulmonology
In this ADVENT symposium at the 2024 European Respiratory Society conference, Dr. Leonard Bacharier describes a typical patient presentation in the pediatric asthma clinic and explores whether clinical remission is a goal of treatment for this patient and others like them.
View more
ERS 2024 | Understanding Remission as a Treatment Goal in Pediatric Severe Asthma – <b>Patient</b> Case Follow-Up
expert video

ERS 2024 | Understanding Remission as a Treatment Goal in Pediatric Severe Asthma – Patient Case Follow-Up

Pulmonology
In this ADVENT symposium at the 2024 European Respiratory Society conference, Dr. Leonard Bacharier revisits a patient case study where a biologic has been added to an asthma management plan and describes the potential for this patient to achieve on-therapy clinical remission.
View more
ERS 2023 | Pediatric Asthma Symposium: <b>Patient</b> Case Discussion
expert video

ERS 2023 | Pediatric Asthma Symposium: Patient Case Discussion

Pulmonology
Join pediatric asthma experts Prof. Giorgio Piacentini and Dr. Sharon Dell for an educational program on the topic of remission in pediatric asthma.
View more
High <b>Burden</b> of Atopic Dermatitis in Children
expert video

High Burden of Atopic Dermatitis in Children

Dermatology
Explore the debilitating effects that impact day-to-day functioning in pediatric patients with atopic dermatitis – a short soundbite from EADV 2022.
View more

ADVENT is a global medical education non-promotional program by Sanofi and Regeneron. This website is intended only for duly authenticated healthcare professionals in Algeria, Argentina, Australia, Austria, Bahrain, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Costa Rica, Croatia, Czech Republic, Denmark, Dominican Republic, Ecuador, Egypt, Estonia, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Iceland, India, Israel, Italy, Japan, Kuwait, Latvia, Lebanon, Lithuania, Macau, Malaysia, Norway, Oman, Panama, Peru, Poland, Portugal, Qatar, Romania, Saudi Arabia, Singapore, Slovenia, South Africa, South Korea, Spain, Sudan, Sweden, Switzerland, Taiwan, Thailand, The Netherlands, Turkey, United Arab Emirates, or the United States of America.

For healthcare professionals in Algeria: Please read the additional Terms of Use.

Sanofi | Regeneron Logo

© 2025 Sanofi and Regeneron Pharmaceuticals, Inc.

All rights reserved.
MAT-GLB-2302957 v3.0 11/2023

All Rights Reserved.

Sanofi and Regeneron are global leaders in pharmaceutical development, each with a long history of supporting frontline physicians to improve human health and reduce the burden of disease. Driven by the same commitment to patients and their families, Sanofi and Regeneron have partnered to take on type 2 inflammation and the range of chronic conditions in which excessive inflammation plays a role.

Country/region: PolandChange country/region